• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常启动子 CpG 甲基化是多种恶性细胞中 PHID3 表达受损的一种机制。

Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells.

机构信息

Molecular and Cellular Biology Program, The University of Iowa, Iowa City, Iowa, United States of America.

出版信息

PLoS One. 2011 Jan 28;6(1):e14617. doi: 10.1371/journal.pone.0014617.

DOI:10.1371/journal.pone.0014617
PMID:21297970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3030558/
Abstract

BACKGROUND

The prolyl-hydroxylase domain family of enzymes (PHD1-3) plays an important role in the cellular response to hypoxia by negatively regulating HIF-α proteins. Disruption of this process can lead to up-regulation of factors that promote tumorigenesis. We observed decreased basal expression of PHD3 in prostate cancer tissue and tumor cell lines representing diverse tissues of origin. Furthermore, some cancer lines displayed a failure of PHD3 mRNA induction when introduced to a hypoxic environment. This study explores the mechanism by which malignancies neither basally express PHD3 nor induce PHD3 under hypoxic conditions.

METHODOLOGY/PRINCIPAL FINDINGS: Using bisulfite sequencing and methylated DNA enrichment procedures, we identified human PHD3 promoter hypermethylation in prostate, breast, melanoma and renal carcinoma cell lines. In contrast, non-transformed human prostate and breast epithelial cell lines contained PHD3 CpG islands that were unmethylated and responded normally to hypoxia by upregulating PHD3 mRNA. Only treatment of cells lines containing PHD3 promoter hypermethylation with the demethylating drug 5-aza-2'-deoxycytidine significantly increased the expression of PHD3.

CONCLUSIONS/SIGNIFICANCE: We conclude that expression of PHD3 is silenced by aberrant CpG methylation of the PHD3 promoter in a subset of human carcinoma cell lines of diverse origin and that this aberrant cytosine methylation status is the mechanism by which these cancer cell lines fail to upregulate PHD3 mRNA. We further show that a loss of PHD3 expression does not correlate with an increase in HIF-1α protein levels or an increase in the transcriptional activity of HIF, suggesting that loss of PHD3 may convey a selective advantage in some cancers by affecting pathway(s) other than HIF.

摘要

背景

脯氨酰羟化酶结构域家族的酶(PHD1-3)通过负调控 HIF-α 蛋白在细胞对缺氧的反应中起着重要作用。该过程的破坏可导致促进肿瘤发生的因子上调。我们观察到前列腺癌组织和代表不同组织来源的肿瘤细胞系中 PHD3 的基础表达降低。此外,一些癌细胞系在引入缺氧环境时显示出 PHD3mRNA 诱导失败。本研究探讨了恶性肿瘤既不在基础水平上表达 PHD3,也不在缺氧条件下诱导 PHD3 的机制。

方法/主要发现:使用亚硫酸氢盐测序和甲基化 DNA 富集程序,我们在前列腺癌、乳腺癌、黑色素瘤和肾细胞癌细胞系中鉴定出人 PHD3 启动子超甲基化。相比之下,未转化的人前列腺和乳腺上皮细胞系中的 PHD3CpG 岛未甲基化,并通过上调 PHD3mRNA 对缺氧正常反应。只有用去甲基化药物 5-氮杂-2'-脱氧胞苷处理含有 PHD3 启动子超甲基化的细胞系,才能显著增加 PHD3 的表达。

结论/意义:我们得出的结论是,在不同起源的人类癌细 胞系中,PHD3 表达被 PHD3 启动子的异常 CpG 甲基化沉默,并且这种异常的胞嘧啶甲基化状态是这些癌细胞系不能上调 PHD3mRNA 的机制。我们进一步表明,PHD3 表达的丧失与 HIF-1α 蛋白水平的增加或 HIF 的转录活性的增加无关,这表明 PHD3 的丧失可能通过影响 HIF 以外的途径而在某些癌症中提供选择性优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/6999968aa317/pone.0014617.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/6fc2eedd3585/pone.0014617.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/1cadf483599b/pone.0014617.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/7d37b653cb1a/pone.0014617.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/8f1191241bcb/pone.0014617.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/a058eb0277c6/pone.0014617.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/6999968aa317/pone.0014617.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/6fc2eedd3585/pone.0014617.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/1cadf483599b/pone.0014617.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/7d37b653cb1a/pone.0014617.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/8f1191241bcb/pone.0014617.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/a058eb0277c6/pone.0014617.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3514/3030558/6999968aa317/pone.0014617.g006.jpg

相似文献

1
Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells.异常启动子 CpG 甲基化是多种恶性细胞中 PHID3 表达受损的一种机制。
PLoS One. 2011 Jan 28;6(1):e14617. doi: 10.1371/journal.pone.0014617.
2
Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.脯氨酰羟化酶PHD1、PHD2、PHD3及天冬酰胺酰羟化酶FIH在结直肠癌中的表达及DNA甲基化水平
BMC Cancer. 2013 Nov 6;13:526. doi: 10.1186/1471-2407-13-526.
3
DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.浸润性乳腺癌中 HIF-1α 脯氨酰羟化酶结构域基因 PHD1、PHD2、PHD3 和因子抑制 HIF 基因 FIH 的 DNA 甲基化分析。
Histopathology. 2010 Sep;57(3):451-60. doi: 10.1111/j.1365-2559.2010.03633.x. Epub 2010 Aug 19.
4
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.缺氧诱导因子-1(HIF-1)通过诱导HIF-α-脯氨酰-4-羟化酶来促进其自身降解。
Biochem J. 2004 Aug 1;381(Pt 3):761-7. doi: 10.1042/BJ20040620.
5
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high mRNA levels in clear cell renal cell carcinoma.缺氧诱导因子 (HIF)-脯氨酰羟化酶 3 (PHD3) 在透明细胞肾细胞癌中维持高 mRNA 水平。
J Biol Chem. 2019 Mar 8;294(10):3760-3771. doi: 10.1074/jbc.RA118.004902. Epub 2019 Jan 7.
6
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.ARHI基因(一种印记肿瘤抑制基因)的异常甲基化和沉默,该基因在乳腺癌中功能丧失。
Cancer Res. 2003 Jul 15;63(14):4174-80.
7
Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.人类癌细胞中鲽鱼钙蛋白-2表达的表观遗传与低氧诱导因子-1调控
Exp Cell Res. 2008 May 1;314(8):1823-30. doi: 10.1016/j.yexcr.2008.03.001. Epub 2008 Mar 8.
8
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.脯氨酰羟化酶与缺氧诱导因子-1α和血管内皮生长因子在人乳腺癌中呈正相关,并对表阿霉素和他莫昔芬的原发性全身治疗有反应而改变。
Breast Cancer Res. 2011 Feb 3;13(1):R16. doi: 10.1186/bcr2825.
9
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.脯氨酰羟化酶 PHD3 增强癌细胞的缺氧存活和 G1 到 S 期转变。
PLoS One. 2011;6(11):e27112. doi: 10.1371/journal.pone.0027112. Epub 2011 Nov 8.
10
Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.缺氧诱导因子 (HIF)-非依赖表达机制及 HIF 脯氨酰羟化酶-3 在肾细胞癌中的新功能。
J Cancer Res Clin Oncol. 2014 Mar;140(3):503-13. doi: 10.1007/s00432-014-1593-7. Epub 2014 Jan 30.

引用本文的文献

1
Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma.理解缺氧驱动的肿瘤发生:HIF1A、DNA 甲基化和脯氨酰羟化酶在头颈部鳞状细胞癌中的相互作用。
Int J Mol Sci. 2024 Jun 12;25(12):6495. doi: 10.3390/ijms25126495.
2
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity.EGLN3 通过抑制 JMJD8/NF-κB 信号激活而不依赖于羟化酶活性来抑制胃癌细胞的恶性特征。
Br J Cancer. 2024 Mar;130(4):597-612. doi: 10.1038/s41416-023-02546-x. Epub 2024 Jan 6.
3

本文引用的文献

1
The redox basis of epigenetic modifications: from mechanisms to functional consequences.表观遗传修饰的氧化还原基础:从机制到功能后果。
Antioxid Redox Signal. 2011 Jul 15;15(2):551-89. doi: 10.1089/ars.2010.3492. Epub 2011 Feb 5.
2
Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells.脯氨酰羟化酶 3 通过与 Bcl-2 相互作用调节 H9c2 细胞中多柔比星诱导的细胞凋亡。
Biochem Biophys Res Commun. 2010 Oct 15;401(2):231-7. doi: 10.1016/j.bbrc.2010.09.037. Epub 2010 Sep 16.
3
DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
PHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway.
PHD3 通过封闭蛋白-p38 通路抑制结肠癌细胞转移。
Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1749-1757. doi: 10.3724/abbs.2023103.
4
One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.一种组学方法并不能解决所有问题:代谢组学与表观基因组学在血液系统恶性肿瘤中携手合作。
Epigenomes. 2021 Oct 8;5(4):22. doi: 10.3390/epigenomes5040022.
5
Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans.暴露组学与外泌体:外泌体作为研究高海拔人群表观遗传适应机制的工具。
Int J Environ Res Public Health. 2021 Aug 5;18(16):8280. doi: 10.3390/ijerph18168280.
6
The roles of inducible chromatin and transcriptional memory in cellular defense system responses to redox-active pollutants.诱导性染色质和转录记忆在细胞防御系统对氧化还原活性污染物反应中的作用。
Free Radic Biol Med. 2021 Jul;170:85-108. doi: 10.1016/j.freeradbiomed.2021.03.018. Epub 2021 Mar 28.
7
Hallmarks of cancer-the new testament.癌症的特征——新约。
Open Biol. 2021 Jan;11(1):200358. doi: 10.1098/rsob.200358. Epub 2021 Jan 20.
8
Hypoxic Regulation of Gene Transcription and Chromatin: Cause and Effect.缺氧对基因转录和染色质的调控:因果关系。
Int J Mol Sci. 2020 Nov 6;21(21):8320. doi: 10.3390/ijms21218320.
9
A model of pulldown alignments from SssI-treated DNA improves DNA methylation prediction.从 SssI 处理的 DNA 中提取下拉对齐模型可提高 DNA 甲基化预测。
BMC Bioinformatics. 2019 Aug 19;20(1):431. doi: 10.1186/s12859-019-3011-2.
10
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression.代谢失调与表观遗传学:双向相互作用推动肿瘤进展。
Cells. 2019 Jul 30;8(8):798. doi: 10.3390/cells8080798.
浸润性乳腺癌中 HIF-1α 脯氨酰羟化酶结构域基因 PHD1、PHD2、PHD3 和因子抑制 HIF 基因 FIH 的 DNA 甲基化分析。
Histopathology. 2010 Sep;57(3):451-60. doi: 10.1111/j.1365-2559.2010.03633.x. Epub 2010 Aug 19.
4
Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2.缺氧诱导因子 (HIF)-3α在人体组织和癌细胞中受到广泛的选择性剪接调控,并受 HIF-1 调节而非 HIF-2。
Int J Biochem Cell Biol. 2010 Jul;42(7):1189-200. doi: 10.1016/j.biocel.2010.04.008. Epub 2010 Apr 21.
5
NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells.NF-κB 促进胰腺癌细胞的上皮-间充质转化、迁移和侵袭。
Cancer Lett. 2010 Sep 28;295(2):214-28. doi: 10.1016/j.canlet.2010.03.003. Epub 2010 Mar 29.
6
Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.脯氨酰羟化酶 EGLN3 通过 NF-κB 依赖的途径调节成肌细胞分化。
J Biol Chem. 2010 Mar 19;285(12):8927-35. doi: 10.1074/jbc.M109.078600. Epub 2010 Jan 10.
7
Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.脯氨酰羟化酶 2 和 3 在神经胶质瘤中作为缺氧诱导因子的保护性负反馈调节因子发挥作用。
Cancer Res. 2010 Jan 1;70(1):357-66. doi: 10.1158/0008-5472.CAN-09-1876. Epub 2009 Dec 22.
8
Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.脯氨酰羟化酶-3 在结直肠癌细胞中下调,并抑制 IKKβ,而不依赖于羟化酶活性。
Gastroenterology. 2010 Feb;138(2):606-15. doi: 10.1053/j.gastro.2009.09.049. Epub 2009 Sep 26.
9
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.浆细胞瘤中,脯氨酰羟化酶 EGLN3 而非 EGLN1 被甲基化失活。
Eur J Haematol. 2010 Jan 1;84(1):47-51. doi: 10.1111/j.1600-0609.2009.01344.x. Epub 2009 Sep 8.
10
BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.BRCA1肿瘤与低氧诱导因子-1α(HIF-1α)表型相关,并且通过调节羟化酶谱表达而预后不良。
Br J Cancer. 2009 Oct 6;101(7):1168-74. doi: 10.1038/sj.bjc.6605287. Epub 2009 Sep 1.